# Unicycive Therapeutics, Inc.: Form 8-K, filed Jun 22, 2026

- Company: [Unicycive Therapeutics, Inc.](/companies/uncy.md) (CIK 1766140)
- Form: 8-K
- Filed: 2026-06-22
- Accepted by EDGAR: Jun 22, 2026, 06:05 ET
- Period: 2026-06-19
- Accession: 0001213900-26-070316
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/ea0295382-8k_unicycive.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/ea0295382-8k_unicycive.htm

Filed Jun 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-070316. Last ingested by Listed: Oct 29, 2026, 16:30 ET. No prices; not investment advice.
